Evaluation

What it does

The module runs structured evaluations in which the assessor does not know whose product or submission is being scored, and the identity of individual reviewers is hidden from the party being assessed. Criteria, weightings, and scoring rubrics are fixed in advance and applied by the same standard to every entry in a category, with no manual override once scoring begins. AI models continuously scan rating patterns to detect collusion, reciprocal favors, coordinated brigading, or any other form of manipulation before results are finalized and published. Every scoring decision, override request, and criteria change is itself logged and auditable, so the evaluation process is transparent even when individual reviewer identities are not.

Every score is backed by underlying evidence: test results, documented specifications, verified transaction history, and prior performance data, not opinion or a written testimonial alone. Big Data analytics benchmark each product or supplier against its category peers on quality, consistency, compliance, and delivery performance, producing an objective ranking instead of a curated review. Once submitted, reviews cannot be edited, purchased, hidden, or removed, so a rating reflects sustained performance over time, not the loudest or best-funded voice in the room.

Key functions

• Structured, blind evaluation that hides identities from both assessors and the assessed
• Quality scoring based on fixed, consistent, and published category-wide criteria
• Verified reviews that cannot be edited, purchased, hidden, or removed
• Objective benchmarking of products and suppliers against direct category peers
• Automated detection of collusion, bias, and coordinated rating manipulation
• Reputation built on documented, auditable evidence rather than marketing claims

In pharma and health

In pharmaceutical procurement and clinical supply decisions, evaluation determines which manufacturers, active ingredients, and distributors an organization can actually trust. Blind assessment removes the influence of brand reputation, sales relationships, and negotiating pressure from quality decisions, so a supplier's real track record on compliance, consistency, and safety determines its standing, not its marketing budget. Procurement teams compare active ingredient sources, contract manufacturers, and logistics partners on the same evidence base, reducing the risk of onboarding a supplier whose documented performance does not match its public reputation. The same blind process applies to laboratory accreditation, contract research partners, and clinical trial vendors, giving quality and compliance teams a consistent standard across every category of supplier they manage.